Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | AZN | AMGN | GILD | BMY |
| Company | Regeneron Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 765.26 | 205.45 | 345.61 | 140.11 | 58.01 |
| High | 775.63 | 206.73 | 351.33 | 140.65 | 59.04 |
| Low | 755.99 | 204.27 | 342.35 | 138.47 | 57.67 |
| Latest | 774.89 | 204.53 | 349.58 | 140.99 | 58.65 |
| Change | +14.62 | +3.72 | +9.58 | +2.19 | +0.98 |
| % Change | +1.92% | +1.85% | +2.82% | +1.58% | +1.70% |
| Volume | 204,330 | 993,959 | 748,769 | 1,070,214 | 4,167,841 |
| 20-Day Average Volume | 585,328 | 1,837,031 | 2,596,599 | 5,902,022 | 13,197,872 |
| Previous Close | 760.27 | 200.81 | 340.00 | 138.80 | 57.67 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 753.62 | 192.61 | 353.85 | 140.27 | 59.05 |
| 20-Day Raw Stochastic | 73.48% | 91.00% | 33.31% | 43.09% | 38.18% |
| 20-Day Relative Strength | 52.08 | 60.05 | 46.23 | 49.34 | 48.95 |
| Weighted Alpha | +40.68 | +53.61 | +22.98 | +35.22 | +21.78 |
| Today's Opinion | 64% Buy | 88% Buy | 40% Buy | 56% Buy | 48% Buy |
| Previous Opinion | 48% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.54% since 03/31/26 | +3.71% since 03/31/26 | -0.50% since 03/31/26 | +0.83% since 03/31/26 | -3.29% since 03/31/26 |
| Low | 745.00 on 04/02/26 | 196.95 on 04/07/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 781.21 on 04/01/26 | 206.73 on 04/08/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +1.13% since 03/06/26 | +5.31% since 03/06/26 | -5.26% since 03/06/26 | -2.36% since 03/06/26 | -2.71% since 03/06/26 |
| Low | 727.88 on 03/19/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 788.69 on 03/10/26 | 206.73 on 04/08/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -4.06% since 01/08/26 | +8.79% since 01/08/26 | +6.05% since 01/08/26 | +16.46% since 01/08/26 | +4.93% since 01/08/26 |
| Low | 718.38 on 01/20/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 821.11 on 01/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +36.29% since 10/08/25 | +19.78% since 10/08/25 | +18.82% since 10/08/25 | +18.84% since 10/08/25 | +31.69% since 10/08/25 |
| Low | 541.00 on 10/13/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 821.11 on 01/09/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 80,375,744 | 311,437,824 | 183,283,120 | 172,281,616 | 117,746,848 |
| Shares Outstanding, K | 105,720 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 14,342,900,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 4,504,900,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 3,884,300,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 844,600,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.40 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 11.44 on 01/30/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/29/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | 0.940 on 02/20/26 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | 02/20/26 | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 21.15 | 22.14 | 15.68 | 17.19 | 9.65 |